Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Imaging Endpoints Announces the Appointment of Joy (Huan) Zhu, M.D., Ph.D., as Vice President, Medical Operations 2022-11-16 21:00
Gracell Biotechnologies Wins 2022 Fierce Life Sciences Innovation Award 2022-11-16 21:00
MediBeacon Receives $10 Million in Amended Agreements with Huadong Medicine to Accelerate Development of Transdermal GFR Measurement System 2022-11-16 19:55
YS Biopharma Received Qualified Person Declaration for Its PIKA COVID-19 Vaccine Facility Equivalent to European Union GMP 2022-11-16 08:50
Simcere and Idorsia enter into a licensing agreement for daridorexant in China 2022-11-16 08:32
Island to present at World Antiviral Congress 2022 2022-11-15 21:00
Alphyn Biologics Completes First Cohort of Phase2a Clinical Trial of Topical Therapeutic for Mild-to-Moderate Atopic Dermatitis 2022-11-15 20:30
Antengene Highlights Encouraging ATG-008 Efficacy Results From TORCH-2 Study in Combination with PD-1 Antibody in Relapsed/Metastatic Cervical Cancer 2022-11-15 16:51
Nona Biosciences Announces Attendance at PEGS Europe 2022 2022-11-15 15:57
Striving Together, Upgrading the Biopharma Industry - International Biopharma Industry Week Shanghai 2022 Kicks Off 2022-11-15 14:17
HARBOUR BIOMED LAUNCHES NONA BIOSCIENCES' "IDEAS TO IND" PRECLINICAL SOLUTIONS BUSINESS TO ACCELERATE GLOBAL BIOTHERAPEUTIC INNOVATION 2022-11-15 12:19
Biotheus has entered into a license and collaboration agreement with Hansoh Pharma for its EGFR/MET bispecific antibody in the Greater China territory 2022-11-15 11:16
LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test 2022-11-14 23:24
RedHill Accelerates Opaganib's Nuclear Radiation Protection Program - Positive Data Published 2022-11-14 20:06
SENTINEL DIAGNOSTICS LAUNCHES SENTINAT® 200, THE FULLY AUTOMATED SAMPLE TO RESULT SYSTEM FOR THE DIAGNOSIS OF VIRAL INFECTIONS 2022-11-14 17:00
Telix Acquires Optimal Tracers 2022-11-14 06:36
Treadwell Therapeutics Announces A Presentation at the 2022 SITC Annual Meeting Featuring a Clinical Trial Update on CFI-402411, a First-in-Class HPK1 inhibitor 2022-11-11 22:09
Telix to Present at Jefferies London Healthcare Conference 2022 2022-11-11 20:00
J INTS BIO, Novel Oral 4th Generation EGFR TKI 'JIN-A02' - Phase 1/2 IND approved by US FDA 2022-11-11 10:30
Bridgewest Group inks deal with Pfizer to acquire injectable manufacturing plant in Western Australia 2022-11-11 10:07
1 103 104 105 106 107 414